Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (28)

1

Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy

enthalten in: AIDS (London, England) | 2020

von Moranguinho, I. | Borrego, P. | Gonçalves, F. | +4

2

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine

enthalten in: AIDS (London, England) | 2014

von Mwafongo, A. | Nkanaunena, K. | Zheng, Y. | +9

3

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting

enthalten in: AIDS (London, England) | 2014

von Clumeck, N. | Mwamba, C. | Kabeya, K. | +9

4

Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy

enthalten in: AIDS (London, England) | 2013

von Martin, A. | Moore, C. | Mallon, P. | +16

5

The effect of antiretrovirals on Plasmodium falciparum liver stages

enthalten in: AIDS (London, England) | 2013

von Hobbs, C. | De La Vega, P. | Penzak, S. | +5

6

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009

enthalten in: AIDS (London, England) | 2013

von Abgrall, S. | Ingle, S. | May, M. | +21

ErratumIn: AIDS. 2014 Jul 31;28(12):1853

7

Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA

enthalten in: AIDS (London, England) | 2012

von Feeney, E. | van Vonderen, M. | Wit, F. | +8

8

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

enthalten in: AIDS (London, England) | 2012

von Bartlett, J. | Ribaudo, H. | Wallis, C. | +11

9

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

enthalten in: AIDS (London, England) | 2012

von Young, J. | Schäfer, J. | Fux, C. | +63

10

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

enthalten in: AIDS (London, England) | 2011

von Haubrich, R. | Riddler, S. | Ribaudo, H. | +8